Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 38 | $25.00 | $950.00 |
DisclosureSEC source: 0000078003-07-000278 · bag1611.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,692 Underlying: Common Stock · 38 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 43 | $25.00 | $1,075.00 |
DisclosureSEC source: 0000078003-07-000279 · can1612.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,341 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 54 | $25.00 | $1,350.00 |
DisclosureSEC source: 0000078003-07-000280 · fec1613.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,096 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 109 | $25.00 | $2,725.00 |
DisclosureSEC source: 0000078003-07-000281 · kin1614.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,730 Underlying: Common Stock · 109 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 214 | $25.00 | $5,350.00 |
DisclosureSEC source: 0000078003-07-000282 · lam1615.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,875 Underlying: Common Stock · 214 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 175 | $25.00 | $4,375.00 |
DisclosureSEC source: 0000078003-07-000283 · rea1616.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,702 Underlying: Common Stock · 175 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 50 | $25.00 | $1,250.00 |
DisclosureSEC source: 0000078003-07-000284 · ric1617.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,222 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 335 | $25.00 | $8,375.00 |
DisclosureSEC source: 0000078003-07-000285 · she1618.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,922 Underlying: Common Stock · 335 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2007 Filed Oct 17, 2007 13:02 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 50 | $25.00 | $1,250.00 |
DisclosureSEC source: 0000078003-07-000286 · wax1619.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,671 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:18 UTC |
CORNWELL W DONDirector
|
GrantPhantom Stock Units · Derivative | 1,369 | $24.43 | $33,444.67 |
DisclosureSEC source: 0000078003-07-000257 · cor1601.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,373 Underlying: Common Stock · 1,369 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:18 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 1,870 | $24.43 | $45,684.10 |
DisclosureSEC source: 0000078003-07-000258 · mea1602.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,370 Underlying: Common Stock · 1,870 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:41 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 40 | $24.43 | $977.20 |
DisclosureSEC source: 0000078003-07-000260 · bag1594.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,654 Underlying: Common Stock · 40 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:18 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 1,279 | $24.43 | $31,245.97 |
DisclosureSEC source: 0000078003-07-000259 · ste1603.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,610 Underlying: Common Stock · 1,279 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 46 | $24.43 | $1,123.78 |
DisclosureSEC source: 0000078003-07-000261 · can1595.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,298 Underlying: Common Stock · 46 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:42 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 61 | $24.43 | $1,490.23 |
DisclosureSEC source: 0000078003-07-000262 · fec1596.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,042 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:42 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 117 | $24.43 | $2,858.31 |
DisclosureSEC source: 0000078003-07-000263 · kin1597.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,621 Underlying: Common Stock · 117 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:42 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 232 | $24.43 | $5,667.76 |
DisclosureSEC source: 0000078003-07-000264 · lam1598.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,661 Underlying: Common Stock · 232 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:42 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 363 | $24.43 | $8,868.09 |
DisclosureSEC source: 0000078003-07-000265 · she1599.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,587 Underlying: Common Stock · 363 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 16:42 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 52 | $24.43 | $1,270.36 |
DisclosureSEC source: 0000078003-07-000266 · wax1600.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,621 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:16 UTC |
MCLEOD MARY SSenior Vice President
|
GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000268 · mcl1605.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,214 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:16 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 186 | $24.43 | $4,543.98 |
DisclosureSEC source: 0000078003-07-000269 · rea1604.xml · derivative · entry 4 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,527 Underlying: Common Stock · 186 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:16 UTC |
READ IAN CSenior Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0000078003-07-000269 · rea1604.xml · derivative · entry 3 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2017-09-27 Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:16 UTC |
READ IAN CSenior Vice President
|
GrantCommon Stock | 4,318 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000269 · rea1604.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,045 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:30 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 52 | $24.43 | $1,270.36 |
DisclosureSEC source: 0000078003-07-000271 · ric1608.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,172 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:33 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 292,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0000078003-07-000272 · dam1606.xml · derivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,000 Underlying: Common Stock · 292,000 shares Expires 2017-09-27 F2 · derivative.exercise_date: One-third of these stock options will vest on each of the first three anniversaries of the grant date if Mr. D'Amelio is employed by the Company on such vesting day. F2 · derivative.underlying: One-third of these stock options will vest on each of the first three anniversaries of the grant date if Mr. D'Amelio is employed by the Company on such vesting day. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:33 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantCommon Stock | 233,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000272 · dam1606.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,280 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| September 27, 2007 Filed Sep 28, 2007 17:20 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000255 · kil1592.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 27, 2007 Filed Sep 28, 2007 17:20 UTC |
NORA JOHNSON SUZANNE MDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000256 · nor1593.xml · derivative · entry 1 NORA JOHNSON SUZANNE M · CIK 0001310264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 40 | $24.29 | $971.60 |
DisclosureSEC source: 0000078003-07-000231 · bag1579.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,614 Underlying: Common Stock · 40 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
CORNWELL W DONDirector
|
PurchaseCommon Stock | 500 | $24.00 | $12,000.00 |
DisclosureSEC source: 0000078003-07-000233 · cor1588.xml · nonDerivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 45 | $24.29 | $1,093.05 |
DisclosureSEC source: 0000078003-07-000232 · can1580.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,252 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 57 | $24.29 | $1,384.53 |
DisclosureSEC source: 0000078003-07-000234 · fec1581.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,981 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 112 | $24.29 | $2,720.48 |
DisclosureSEC source: 0000078003-07-000235 · kin1582.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,504 Underlying: Common Stock · 112 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 226 | $24.29 | $5,489.54 |
DisclosureSEC source: 0000078003-07-000236 · lam1583.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,429 Underlying: Common Stock · 226 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 345 | $24.29 | $8,380.05 |
DisclosureSEC source: 0000078003-07-000237 · lev1584.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,887 Underlying: Common Stock · 345 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 183 | $24.29 | $4,445.07 |
DisclosureSEC source: 0000078003-07-000238 · rea1585.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,341 Underlying: Common Stock · 183 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 352 | $24.29 | $8,550.08 |
DisclosureSEC source: 0000078003-07-000239 · she1586.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,224 Underlying: Common Stock · 352 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:02 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 51 | $24.29 | $1,238.79 |
DisclosureSEC source: 0000078003-07-000240 · wax1587.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,569 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 37 | $24.84 | $919.08 |
DisclosureSEC source: 0000078003-07-000217 · bag1569.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,574 Underlying: Common Stock · 37 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 41 | $24.84 | $1,018.44 |
DisclosureSEC source: 0000078003-07-000218 · can1570.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,207 Underlying: Common Stock · 41 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 44 | $24.84 | $1,092.96 |
DisclosureSEC source: 0000078003-07-000219 · fec1571.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,924 Underlying: Common Stock · 44 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 102 | $24.84 | $2,533.68 |
DisclosureSEC source: 0000078003-07-000220 · kin1572.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,392 Underlying: Common Stock · 102 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 185 | $24.84 | $4,595.40 |
DisclosureSEC source: 0000078003-07-000221 · lam1573.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,203 Underlying: Common Stock · 185 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 295 | $24.84 | $7,327.80 |
DisclosureSEC source: 0000078003-07-000222 · lev1574.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,542 Underlying: Common Stock · 295 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 139 | $24.84 | $3,452.76 |
DisclosureSEC source: 0000078003-07-000223 · rea1575.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,158 Underlying: Common Stock · 139 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 287 | $24.84 | $7,129.08 |
DisclosureSEC source: 0000078003-07-000224 · she1576.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,872 Underlying: Common Stock · 287 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 17:54 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 49 | $24.84 | $1,217.16 |
DisclosureSEC source: 0000078003-07-000225 · wax1577.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,518 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 83 | $23.53 | $1,952.99 |
DisclosureSEC source: 0000078003-07-000204 · bag1560.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,537 Underlying: Common Stock · 83 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 133 | $23.53 | $3,129.49 |
DisclosureSEC source: 0000078003-07-000205 · can1561.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,166 Underlying: Common Stock · 133 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 310 | $23.53 | $7,294.30 |
DisclosureSEC source: 0000078003-07-000206 · fec1562.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,880 Underlying: Common Stock · 310 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.